GIST and CML
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator (NCT01742299) | Novartis Pharmaceuticals | 2013-03-26 |
Track GIST and CML automatically
Every clearance here is in the API, with alerts when new ones post.